Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 1/2004

01-03-2004 | CASE REPORT

A rare case of Graves’ disease during regular hemodialysis

Authors: Seitaro Maruyama, Tomoo Ikarashi, Satoshi Soda, Maki Toya, Kazuki Okamura, Satoshi Hirayama, Katsunori Suzuki, Osamu Hanyu, Tai Sakurabayashi, Osamu Nakagawa, Yoshifusa Aizawa

Published in: Clinical and Experimental Nephrology | Issue 1/2004

Login to get access
Metadata
Title
A rare case of Graves’ disease during regular hemodialysis
Authors
Seitaro Maruyama
Tomoo Ikarashi
Satoshi Soda
Maki Toya
Kazuki Okamura
Satoshi Hirayama
Katsunori Suzuki
Osamu Hanyu
Tai Sakurabayashi
Osamu Nakagawa
Yoshifusa Aizawa
Publication date
01-03-2004
Publisher
Springer-Verlag
Published in
Clinical and Experimental Nephrology / Issue 1/2004
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-003-0264-9

Other articles of this Issue 1/2004

Clinical and Experimental Nephrology 1/2004 Go to the issue

ORIGINAL ARTICLE

Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis

CASE REPORT

Immune complex-type glomerulonephritis with unusual giant deposits in a patient with active rheumatoid arthritis

ORIGINAL ARTICLE

Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure

CASE REPORT

Membranous nephropathy complicated by renal cell carcinoma

ORIGINAL ARTICLE

Insulin-like growth factor-I increases p21 expression and attenuates cisplatin-induced acute renal injury in rats

REVIEW ARTICLE

Defects in processing and trafficking of the AE1 Cl−/HCO3− exchanger associated with inherited distal renal tubular acidosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits